Caspase-3: Structure, function, and biotechnological aspects

被引:335
作者
Asadi, Marzieh [1 ]
Taghizadeh, Saeed [1 ]
Kaviani, Elina [1 ]
Vakili, Omid [2 ]
Taheri-Anganeh, Mortaza [1 ]
Tahamtan, Mahshid [3 ]
Savardashtaki, Amir [1 ]
机构
[1] Shiraz Univ Med Sci, Dept Med Biotechnol, Sch Adv Med Sci & Technol, Shiraz, Iran
[2] Shiraz Univ Med Sci, Dept Clin Biochem, Sch Pharm & Pharmaceut Sci, Esfahan, Iran
[3] Shiraz Univ Med Sci, Dept Neurosci, Sch Adv Med Sci & Technol, Shiraz, Iran
关键词
apoptosis; biotechnology; caspase-3; diseases; therapeutics; LONG-TERM DEPRESSION; Q-VD-OPH; CELL-DEATH; ALZHEIMERS-DISEASE; MOLECULAR-CLONING; ACTIVE CASPASE-3; GENE-THERAPY; DIFFERENTIATION; ACTIVATION; APOPTOSIS;
D O I
10.1002/bab.2233
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Caspase-3, a cysteine-aspartic acid protease, has recently attracted much attention because of its incredible roles in tissue differentiation, regeneration, and neural development. This enzyme is a key zymogen in cell apoptosis and is not activated until it is cleaved by initiator caspases during apoptotic flux. Since caspase-3 has represented valuable capabilities in the field of medical research, biotechnological aspects of this enzyme, including the production of recombinant type, protein engineering, and designing delivery systems, have been considered as emerging therapeutic strategies in treating the apoptosis-related disorders. To date, several advances have been made in the therapeutic use of caspase-3 in the management of some diseases such as cancers, heart failure, and neurodegenerative disorders. In the current review, we intend to discuss the caspase-3's structure, functions, therapeutic applications, as well as its molecular cloning, protein engineering, and relevant delivery systems.
引用
收藏
页码:1633 / 1645
页数:13
相关论文
共 92 条
[81]   Suitable signal peptides for secretory production of recombinant granulocyte colony stimulating factor in Escherichia coli [J].
Tehrani S.S. ;
Goodarzi G. ;
Naghizadeh M. ;
Khatami S.H. ;
Movahedpour A. ;
Abbasi A. ;
Shabaninejad Z. ;
Khalaf N. ;
Taheri-Anganeh M. ;
Savardashtaki A. .
Recent Patents on Biotechnology, 2020, 14 (04) :269-282
[82]   Caspase-1 activity is required for neuronal differentiation of PC12 cells: Cross-talk between the caspase and calpain systems [J].
Vaisid, T ;
Kosower, NS ;
Barnoy, S .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2005, 1743 (03) :223-230
[83]   A constitutively active and uninhibitable caspase-3 zymogen efficiently induces apoptosis [J].
Walters, Jad ;
Pop, Cristina ;
Scott, Fiona L. ;
Drag, Marcin ;
Swartz, Paul ;
Mattos, Carla ;
Salvesen, Guy S. ;
Clark, A. Clay .
BIOCHEMICAL JOURNAL, 2009, 424 :335-345
[84]   Caspase activation in the terminal differentiation of human epidermal keratinocytes [J].
Weil, M ;
Raff, MC ;
Braga, VMM .
CURRENT BIOLOGY, 1999, 9 (07) :361-364
[85]   Caspases in metabolic disease and their therapeutic potential [J].
Wilson, Claire H. ;
Kumar, Sharad .
CELL DEATH AND DIFFERENTIATION, 2018, 25 (06) :1010-1024
[86]   Apoptosis in cancer: from pathogenesis to treatment [J].
Wong, Rebecca S. Y. .
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2011, 30
[87]   Cancer gene therapy using a pro-apoptotic gene, caspase-3 [J].
Yamabe, K ;
Shimizu, S ;
Ito, T ;
Yoshioka, Y ;
Nomura, M ;
Narita, M ;
Saito, I ;
Kanegae, Y ;
Matsuda, H .
GENE THERAPY, 1999, 6 (12) :1952-1959
[88]  
Yan XX, 2012, CURR GERIATR REP, V1, P85, DOI 10.1007/s13670-012-0009-2
[89]   Caspase-3 as a therapeutic target for heart failure [J].
Yang, Bo ;
Ye, Dewei ;
Wang, Yu .
EXPERT OPINION ON THERAPEUTIC TARGETS, 2013, 17 (03) :255-263
[90]   Caspase activation is required for terminal erythroid differentiation [J].
Zermati, Y ;
Garrido, C ;
Amsellem, S ;
Fishelson, S ;
Bouscary, D ;
Valensi, F ;
Varet, B ;
Solary, E ;
Hermine, O .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 193 (02) :247-254